CPHA Canvax

Presentation highlights:

  • To provide a brief overview of NACI guidance in the context of public health decision making
  • To describe the efficacy and effectiveness of COVID-19 vaccines in the context of one or two doses
  • To discuss the impacts of extended dose intervals of COVID-19 vaccines
  • To present the NACI recommendations on extended dose intervals. 
Rating See Comments Ratings

Category:

Vaccine Safety and Development,Program Planning and Delivery,Research and Development,Vaccine Management,Vaccine Effectiveness and Efficacy,Allocation and Distribution,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Program Planning and Delivery
Research and Development
Vaccine Management
Vaccine Effectiveness and Efficacy
Allocation and Distribution
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.